Expect the unexpected: fulminant myocardial cytotoxic Injury from Trabectedin
Abstract Background Trabectedin (Tbt) is an alkylating agent prescribed for soft tissue sarcomas after treatment failure of first line agents. While cardiomyopathy can occur with Tbt treatment after anthracycline exposure, Tbt-induced fulminant myocardial cytotoxic injury in the setting of other sys...
Główni autorzy: | , , , , , , , , , , , , , , |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
BMC
2024-10-01
|
Seria: | Cardio-Oncology |
Hasła przedmiotowe: | |
Dostęp online: | https://doi.org/10.1186/s40959-024-00257-7 |